Article
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy.
Current opinion in hematology - 1 Mar 2011
Bhatia Ravi, Deeg H Joachim
Abstract excerpt
PURPOSE OF REVIEW: Treatment-related myelodysplastic syndrome (t-MDS) is a serious complication of cancer treatment. Here we review recent advances in knowledge of the risk factors, pathogenesis, and treatment of t-MDS. RECENT FINDINGS: Recent studies have provided important new information regarding genetic risk factors that may predispose individual patients to develop t-MDS after exposure to cytotoxic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
